Evrysdi Approved in Europe as First Oral, At-home Treatment & The Evrysdi Chronicles

SMA News Today’s multimedia associate, Price Wooldridge, discusses Evrysdi’s approval in Europe as the first oral, at-home treatment for Spinal Muscular Atrophy (SMA).

Also, DeAnn Runge reads the latest column from Brianna Albers as she continues the quest to start the SMA treatment Evrysdi, The Evrysdi Chronicles: Full Speed Ahead.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/